2. Gene
  3. NAPEPLD - N-acyl phosphatidylethanolamine phospholipase D Gene

NAPEPLD - N-acyl phosphatidylethanolamine phospholipase D Gene

  • Gene
  • Protein
  • Disease
  • Agent
  • Ortholog
Homo sapiens

Also known as FMP30; C7orf18; NAPE-PLD

Gene ID: 222236 | Gene type: protein coding

About NAPEPLD

Cytogenetic location: 7q22.1 Genomic coordinates (GRCh38): 7:103,099,776-103,150,001 (from NCBI)

This gene has 10 transcripts (splice variants), 1 gene allele and 220 orthologues. Ubiquitous expression in brain (RPKM 8.2), kidney (RPKM 8.2) and 25 other tissues.

Summary

NAPEPLD is a Phospholipase D type Enzyme that catalyzes the release of N-acylethanolamine (NAE) from N-acyl-phosphatidylethanolamine (NAPE) in the second step of the biosynthesis of N-acylethanolamine (Okamoto et al., 2004 [PubMed 14634025]).[supplied by OMIM, Oct 2008]

NAPEPLD Products(21)

mRNA Protein Name
NM_001122838.3 NP_001116310.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386176.1 NP_001373105.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386177.1 NP_001373106.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386179.1 NP_001373108.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386182.1 NP_001373111.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386185.1 NP_001373114.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386189.1 NP_001373118.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 4
NM_001386190.1 NP_001373119.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386191.1 NP_001373120.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386193.1 NP_001373122.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386194.1 NP_001373123.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386204.1 NP_001373133.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386205.1 NP_001373134.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 2
NM_001386207.1 NP_001373136.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 2
NM_001386208.1 NP_001373137.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386209.1 NP_001373138.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386210.1 NP_001373139.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 3
NM_001386211.1 NP_001373140.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 2
NM_001386212.1 NP_001373141.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_001386213.1 NP_001373142.1 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1
NM_198990.6 NP_945341.3 N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D isoform 1

NAPEPLD Protein Structure

Lactamase_B_2

Lactamase_B_2: Beta-lactamase superfamily domain (144 - 344)

  • 0
  • 100
  • 200
  • 300
  • 393 a.a.
Protein Preferred Names Protein Names

N-acyl-phosphatidylethanolamine-hydrolyzing phospholipase D

NAPE-hydrolyzing phospholipase D

Related Diseases

Diseases Alias
Vulvar Syringoma
Cannabis Abuse

Marijuana Abuse
Cannabis Dependence

Marijuana Abuse

Cannabinoid Addiction

Cannabinoid Dependence

Cannabis Addiction
Hallucinogen Dependence

Hallucinogen Addiction
Lennox-Gastaut Syndrome

Lennox Syndrome

Encephalopathy Of Childhood

Epileptic Encephalopathy Lennox-Gastaut Type

Childhood Epileptic Encephalopathy With Diffuse Slow Spikes And Waves

Lgs
Diseases Alias
Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Waldenstroem'S Macroglobulinemia

Waldenstroem'S Macroglobulinemia

Macroglobulinemia Of Waldenstrom

Lymphoplasmacytic Lymphoma With Igm Gammopathy

Lymphoplasmacytic Lymphoma

Related Agents

Pre-clinical Phase
Bioactive Molecules (5)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-131181 LEI-401 Inhibitor 99.79% Unkown
HY-155774 VU533 99.71% Unkown
HY-155773 VU534 Inhibitor 98.53% Unkown
HY-118994 ARN19874 Inhibitor 99.54% Unkown
HY-RS09031 NAPEPLD Human Pre-designed siRNA Set A / Unkown

Orthologs Information

Species Symbol Source ID
Bos taurus NAPEPLD VGNC VGNC:31883
Rattus norvegicus NAPEPLD RGD RGD:735197
Felis catus NAPEPLD VGNC VGNC:63721
Canis familiaris NAPEPLD VGNC VGNC:43621
Mus musculus NAPEPLD MGD MGI:2140885
Macaca mulatta NAPEPLD VGNC VGNC:75001